Claims for Patent: 9,326,969
✉ Email this page to a colleague
Summary for Patent: 9,326,969
Title: | Compositions |
Abstract: | The invention provides a colon cleansing solution comprising: a) 300 to 800 mmol per litre ascorbate anion provided by a mixture of: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per litre polyethylene glycol. The invention also provides methods and kits associated with, or making use of the solutions, and compositions for the preparation of the solutions. |
Inventor(s): | Clayton; Lucy (Uxbridge, GB), Cockett; Alasdair (Uxbridge, GB), Christodoulou; Mark (Uxbridge, GB), Davidson; Ian (Uxbridge, GB), Farrag; Lynn (Uxbridge, GB), Halphen; Marc (London, GB), Jones; Leighton (Uxbridge, GB), Petrossian; Vanik (Woburn, MA), Stein; Peter (Amsterdam Zuid-Oost, NL), Tisi; David (Woburn, MA), Ungar; Alex (Wigton, GB), Worthington; Jeffrey (Woburn, MA) |
Assignee: | NORGINE BV (Amsterdam Zuid Oost, NL) |
Application Number: | 14/657,495 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,326,969 |
Patent Claims: |
1. A method of cleansing the colon or bowel wherein the subject takes a colon cleansing solution comprising: a) an ascorbate component comprising 300 to 800 mmol per liter ascorbate
anion provided by a mixture of: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per liter polyethylene glycol.
2. A method as claimed in claim 1 wherein the colon cleansing solution comprises 60 to 140 g/liter of ascorbate component. 3. A method as claimed in claim 1 wherein the colon cleansing solution comprises 12 to 20 g/liter of ascorbic acid and 80 to 120 g/liter of sodium ascorbate. 4. A method as claimed in claim 1 wherein the polyethylene glycol has an average molecular weight 2500 to 4500 Da. 5. A method as claimed in claim 1 wherein the colon cleansing solution comprises 20 to 160 g per liter of PEG. 6. A method as claimed in claim 1 wherein the colon cleansing solution comprises sodium chloride at a concentration of 3 to 8 g per liter. 7. A method as claimed in claim 1 wherein the colon cleansing solution comprises potassium chloride at a concentration of 1 to 10 g per liter. 8. A method as claimed in claim 1 wherein the colon cleansing solution comprises a flavouring agent and/or a sweetener. 9. A method as claimed in claim 1 wherein the colon cleansing solution consists essentially of: a) (iii) 14 to 16 g per liter ascorbic acid and (iv) 92 to 100 g per liter sodium ascorbate b) 75 to 85 g per liter PEG having an average molecular weight of 3000 to 4000 Da; c) 6.0 to 6.8 g per liter sodium chloride and 2.0 to 2.8 g per liter potassium chloride; e) one or more flavouring agents; and f) one or more sweeteners. 10. A method as claimed in claim 1 wherein the subject takes the cleansing solution in a single dose. 11. A method as claimed in claim 10 wherein the dose is of a volume of 700 ml to 1500 ml, and the subject optionally ingests some additional clear fluid after ingesting the solution. 12. A method as claimed in claim 1 wherein the subject takes the cleansing solution in a split dose, two doses being separated by a time interval. 13. A method as claimed in claim 12 wherein two doses are taken separated by an overnight interval, or wherein two doses are taken on the same day. 14. A method as claimed in claim 13 wherein each dose is of a volume of 300 ml to 1000 ml, and the subject optionally ingests some additional clear fluid after ingesting each or either dose of the solution. 15. A method of cleansing the colon of a subject comprising: administering to the subject an effective amount of a first colon cleansing solution; administering to the subject an effective amount of a second colon cleansing solution, the first colon cleansing solution or the second colon cleansing solution being a solution comprising: a) an ascorbate component comprising 300 to 800 mmol per liter ascorbate anion provided by a mixture of: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per liter polyethylene glycol. 16. A method as claimed in claim 15 wherein the first colon cleansing solution comprises: (i) 70 to 250 g per liter PEG having an average molecular weight of 2500 to 4500 Da; (ii) 2.0 to 20 g per liter of one or more alkali metal sulphates, alkaline earth metal sulphates or a mixture thereof; (iii) optionally one or more electrolytes; (iv) optionally one or more flavouring agents; and (v) optionally one or more sweeteners. and the second colon cleansing solution comprises: a) an ascorbate component comprising 300 to 800 mmol per liter ascorbate anion provided by a mixture of: (i) ascorbic acid and (ii) one or more salts of ascorbic acid the components (i) and (ii) being present in a molar ratio of from 1:4.5 to 1:7.0; and b) 10 to 200 g per liter polyethylene glycol. 17. A method as claimed in claim 15 wherein first cleansing solution has a volume of 200 ml to 1000 ml, and the second cleansing solution has a volume of 200 ml to 1000 ml. 18. A method as claimed in claim 17 wherein first cleansing solution has a volume of 500 ml or 750 ml, and the second cleansing solution has a volume of 500 ml. 19. A method as claimed in claim 15 in which the subject takes additional clear fluid after one or both of the first and second colon cleansing solutions. 20. A method as claimed in claim 19, in which the subject takes 300 ml to 1000 ml of additional clear fluid after each of the first and second colon cleansing solutions. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.